Directory
>
Garry Nicholson
Garry Nicholson
Member Board of Directors | G1 Therapeutics, Inc.
Chapel Hill, North Carolina, United States
Garry Nicholson
Summary
Garry Nicholson is a seasoned executive in the pharmaceutical and biotechnology sectors, currently serving as the Chair of the Board of Directors at G1 Therapeutics, Inc. With extensive experience in clinical development, drug commercialization, and governance, he has held pivotal roles in various organizations, including Tscan Therapeutics and Day One Biopharmaceuticals. Garry's career spans over four decades, beginning as a Sales/Marketing Leader at Eli Lilly and evolving into high-level positions such as President of Oncology at Pfizer. He holds an MBA from the University of South Carolina and a BS in Pharmacy from the University of North Carolina at Chapel Hill. His leadership is characterized by a focus on oncology and innovative drug development, making significant contributions to the advancement of cancer therapies. Outside of board roles, Garry is known for his strategic insights and commitment to improving patient outcomes through effective pharmaceutical solutions.
Garry Nicholson
Work Experience
Member Board of Directors at
TScan Therapeutics
June 2024 - Present
Chairman of the Board of Directors at
Day One Biopharmaceuticals
October 2022 - Present
Chair of the Board of Directors at
Abdera Therapeutics
September 2022 - Present
Chair Of The Board Of Directors at
G1 Therapeutics, Inc.
June 2019 - Present
Member Board Of Directors at
G1 Therapeutics, Inc.
September 2018 - Present
Member Board of Directors at
NextCure, Inc.
March 2020 - September 2023
Member Board Of Directors at
Tmunity Therapeutics Incorporated
February 2019 - December 2022
Member Board of Directors at
Bristol Myers Squibb
January 2020 - June 2022
Member Board Of Directors at
Five Prime Therapeutics, Inc.
May 2017 - February 2021
Member Board Of Directors at
)
November 2018 - December 2020
Member Board of Directors at
Sqz Biotechnologies Company
December 2015 - March 2020
Member Board of Directors at
Tesaro, Inc.
May 2015 - January 2019
Member Board Of Directors at
Xtuit Pharmaceuticals
September 2015 - March 2018
President and Chief Executive Officer at
Xtuit Pharmaceuticals
September 2015 - October 2016
President, Oncology at
Pfizer, Inc.
May 2008 - April 2015
Global Oncology Platform Leader at
Eli Lilly and Company
January 2005 - January 2008
Executive Director, Corporate Six Sigma Task Force at
Eli Lilly and Company
January 2004 - January 2005
Executive Director, U.S. Oncology Business Unit at
Eli Lilly and Company
January 1997 - January 2004
Sales/Marketing Leader at
Eli Lilly and Company
August 1979 - January 1997
Garry Nicholson
Education
University of North Carolina at Chapel Hill, Bachelor Of Science (Bs)
January 1977
University of South Carolina, Master Of Business Administration (Mba)
January 1978
Frequently Asked Questions about Garry Nicholson
What is Garry Nicholson email address?
Garry Nicholson's primary email address is ***************@tptherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Garry Nicholson work for?
Garry Nicholson is a Member Board of Directors at G1 Therapeutics, Inc., a company specializing in Commercial physical research.
Where Garry Nicholson graduated from?
Garry Nicholson holds a degree in Pharmacy from University of North Carolina at Chapel Hill.
How can I directly contact Garry Nicholson?
To contact Garry Nicholson directly, you can use the email address ***************@tptherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Garry Nicholson?
Garry Nicholson is a seasoned executive in the pharmaceutical and biotechnology sectors, currently serving as the Chair of the Board of Directors at G1 Therapeutics, Inc. With extensive experience in clinical development, drug commercialization, and governance, he has held pivotal roles in various organizations, including Tscan Therapeutics and Day One Biopharmaceuticals. Garry's career spans over four decades, beginning as a Sales/Marketing Leader at Eli Lilly and evolving into high-level positions such as President of Oncology at Pfizer. He holds an MBA from the University of South Carolina and a BS in Pharmacy from the University of North Carolina at Chapel Hill. His leadership is characterized by a focus on oncology and innovative drug development, making significant contributions to the advancement of cancer therapies. Outside of board roles, Garry is known for his strategic insights and commitment to improving patient outcomes through effective pharmaceutical solutions.
Garry`s contact details
***************@tptherapeutics.com
***************@dayonebio.com
**********@nextcure.com
Colleagues
VP, Market Access
Vice President, Finance
Chief Commercial Officer
Chief of Staff and Senior Director of Corporate Development
Vice President Information Technology